MARKET

ELUT

ELUT

Elutia Inc.
NASDAQ
0.6927
+0.1097
+18.82%
After Hours: 0.6921 -0.0006 -0.09% 19:00 12/31 EST
OPEN
0.5835
PREV CLOSE
0.5830
HIGH
0.7348
LOW
0.5699
VOLUME
1.05M
TURNOVER
--
52 WEEK HIGH
3.990
52 WEEK LOW
0.5000
MARKET CAP
29.58M
P/E (TTM)
-1.0146
1D
5D
1M
3M
1Y
5Y
1D
ELUTIA INC (ELUT) Upgraded to Buy: Here's What You Should Know
NASDAQ · 12/31/2025 17:00
Weekly Report: what happened at ELUT last week (1222-1226)?
Weekly Report · 12/29/2025 09:21
Weekly Report: what happened at ELUT last week (1215-1219)?
Weekly Report · 12/22/2025 09:21
Friday's After-Hours Gainers: Biotech And Genomics Stocks Show Strength
NASDAQ · 12/22/2025 04:20
Top Executive Makes Bold Insider Move on Elutia Stock
TipRanks · 12/20/2025 02:05
Director and 10% Owner Kevin Rakin Acquires Common Shares of Elutia Inc
Reuters · 12/19/2025 22:00
Insiders Make Bold Move on Elutia Stock With Fresh Buying Spree
TipRanks · 12/19/2025 02:05
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 12/18/2025 17:06
More
About ELUT
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Women’s Health and Cardiovascular markets. In Women’s Health, it offers SimpliDerm, a novel biological matrix that leverages the inherent science of natural healing processes. SimpliDerm's design uses human-based hydrated acellular dermal matrix (ADM), which mitigates inflammation and enhances tissue incorporation. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. In addition, its TYKE product is designed for use in the neonatal patient population. It is focused on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections following mastectomy. NXT-41x combines biologics and extended antibiotic release to provide protection while supporting tissue regeneration.

Webull offers Elutia Inc stock information, including NASDAQ: ELUT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELUT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELUT stock methods without spending real money on the virtual paper trading platform.